Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses.
Resource Type
Article
Authors
Novak, Frederik ; Bajwa, Hamza Mahmood ; Coia, John Eugenio ; Nilsson, Anna Christine ; Nielsen, Christian ; Holm, Dorte K. ; Østergaard, Kamilla ; Hvidt, Mathilde Vilhelmine Miller ; Byg, Keld-Erik ; Johansen, Isik S. ; Mittl, Kristen ; Rowles, William ; Zamvil, Scott S. ; Bove, Riley ; Sabatino Jr, Joseph J. ; Sejbaek, Tobias
Source
Journal of Neurology, Neurosurgery & Psychiatry; Nov2023, Vol. 94 Issue 11, p934-937, 4p
Subject
BREAKTHROUGH infections MULTIPLE sclerosis DISEASE progression MESSENGER RNA BOOSTER vaccines
Language
ISSN
00223050